【発明の名称】マイコバクテリウム感染検出合成ポリペプチド

Title:

【発明の名称】マイコバクテリウム感染検出合成ポリペプチド

Document Type and Number:

Japanese Patent JPH0762030

Kind Code:

B2

Abstract:

Antigens, immunogens, inocula, antibodies, receptors, diagnostic methods and systems relating to tuberculosis mycobacteria are disclosed. Each of the compounds, compositions, methods or systems contains about 40 residues, or an antibody containing site that immunoreacts with such a polypeptide. The polypeptide includes the thirteen or fourteen amino acid reside sequence (AlaLysValAsnIleLysProLeuGluAspLysIleCys) or (CysAlaLysValAsnIleLysproLeuGluAspLysIleCys). When linked to a carrier and introduced in an effective amount into a mammalian host, the polypeptide is capable of inducing production of antibodies that immunoreact with an antigen to a tuberculous mycobacterium.

More Like This:

WO/2019/192973	DIAGNOSTIC ASSAYS TO DETECT TUMOR ANTIGENS IN CANCER PATIENTS
JP2022089759	VARIANTS OF SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF
WO/2010/057983	SALMONELLA MARKER VACCINE

Inventors:

Scenic Thomas M
Minden Percy
Hoten Richard A

Application Number:

JP50460886A

Publication Date:

July 05, 1995

Filing Date:

August 12, 1986

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Scripts Klitnik and Lisa

International Classes:

G01N33/569; A01K39/04; A61K39/04; A61P31/04; A61P31/06; C07K7/08; C07K14/00; C07K14/195; C07K14/35; C07K14/41; C07K14/705; C07K16/00; C07K16/12; C07K19/00; C12P21/08; A61K39/00; (IPC1-7): C07K7/08; A61K39/04; G01N33/569

Attorney, Agent or Firm:

Minoru Nakamura (5 others)

Next Patent: エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を�...